Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correcting Residual Errors With Spectral, Ultrasound, and Traditional Speech Therapy: Delineation of Sensorimotor Subtypes

NCT03736213 is registered in ClinicalTrials.gov with New York University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correcting Residual Errors With Spectral, Ultrasound, and Traditional Speech Therapy: Delineation of Sensorimotor Subtypes
Lead sponsor
New York University
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2019
Completion date
February 1, 2022
Enrollment
7 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.